Author:
ter Veer Emil,Haj Mohammad Nadia,van Valkenhoef Gert,Ngai Lok Lam,Mali Rosa M. A.,van Oijen Martijn G. H.,van Laarhoven Hanneke W. M.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 65(2), 87–108. doi: 10.3322/caac.21262 .
2. Wagner, A. D., Unverzagt, S., Grothe, W., Kleber, G., Grothey, A., Haerting, J., et al. (2010). Chemotherapy for advanced gastric cancer. Cochrane database of systematic reviews (Online), 3, CD004064.
3. Kim, H. S., Kim, H. J., Kim, S. Y., Kim, T. Y., Lee, K. W., Baek, S. K., et al. (2013). Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Annals of Oncology, 24(11), 2850–2854. doi: 10.1093/annonc/mdt351 .
4. Janowitz, T., Thuss-Patience, P., Marshall, A., Kang, J. H., Connell, C., Cook, N., et al. (2016). Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data. British Journal of Cancer, 114(4), 381–387. doi: 10.1038/bjc.2015.452 .
5. Fuchs, C., Tomasek, J., Yong, C., Dumitru, F., Passalacqua, R., Goswami, C., et al. (2014). Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet, 383(9911), 31–39. doi: 10.1016/S0140-6736(13)61719-5 .
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献